HCA vs NDRA · P/E 17, rev $75.60B vs P/E 0.0, $2.6M cap
HCA Holdings Inc (HCA) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
HCA Holdings Inc (HCA) is a medical care facilities company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported HCA revenue for 2025-12-31 was $75.60B. Net income was $6.78B. Revenue was up 7.1% from 2024-12-31 to 2025-12-31. HCA currently screens at market cap $91.01B and trailing P/E 16.8.
NDRA does not have a complete income-statement cache yet.
HCA currently screens at market cap $91.01B and trailing P/E 16.8. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the HCA and NDRA stock pages for the full models.
Not investment advice.